Published in Transl Psychiatry on March 14, 2017
Neuronal oscillations in cortical networks. Science (2004) 19.57
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Interneurons of the hippocampus. Hippocampus (1996) 12.61
The mGluR theory of fragile X mental retardation. Trends Neurosci (2004) 8.88
Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci (2002) 8.74
Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord (1980) 7.07
On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science (2002) 5.87
Neuron number and size in prefrontal cortex of children with autism. JAMA (2011) 4.73
Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A (2010) 4.02
Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci (2003) 3.87
A synaptic trek to autism. Curr Opin Neurobiol (2009) 3.53
Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science (2014) 3.44
Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry (2009) 3.16
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet (2009) 2.76
Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry (2004) 2.54
Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci Transl Med (2012) 2.51
Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury. Nat Med (2010) 2.45
Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery. Science (2006) 2.36
Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci (2009) 2.33
Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med (2011) 1.96
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Sci Transl Med (2016) 1.94
Peripheral Mechanosensory Neuron Dysfunction Underlies Tactile and Behavioral Deficits in Mouse Models of ASDs. Cell (2016) 1.58
Cation-chloride cotransporters in neuronal development, plasticity and disease. Nat Rev Neurosci (2014) 1.50
A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry (2012) 1.29
Molecular regulation of NKCC2 in the thick ascending limb. Am J Physiol Renal Physiol (2011) 1.28
The GABA excitatory/inhibitory developmental sequence: a personal journey. Neuroscience (2014) 1.22
The developmental switch in GABA polarity is delayed in fragile X mice. J Neurosci (2014) 1.14
The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol Psychiatry (2015) 1.11
Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital. Brain (2011) 1.06
Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs (1984) 1.03
Bumetanide and frusemide: a comparison of dose-response curves in healthy men. Br J Clin Pharmacol (1978) 1.02
Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury. Ann N Y Acad Sci (2010) 1.01
Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. CNS Drugs (2009) 1.00
Neuro-archaeology: pre-symptomatic architecture and signature of neurological disorders. Trends Neurosci (2008) 0.99
Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci Transl Med (2014) 0.95
The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects. Acta Paediatr (2010) 0.94
Developmental effects of neonatal isoflurane and sevoflurane exposure in rats. Anesthesiology (2013) 0.94
Pre-eclampsia, birth weight, and autism spectrum disorders. J Autism Dev Disord (2010) 0.92
Comparative efficacy and safety of bumetanide and furosemide in long-term treatment of edema due to congestive heart failure. J Clin Pharmacol (1982) 0.92
Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new "loop" diuretic. Pharmacotherapy (1983) 0.88
Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr (1992) 0.86
Lack of effect of risperidone on core autistic symptoms: data from a longitudinal study. J Child Adolesc Psychopharmacol (2014) 0.84
Treating Fragile X syndrome with the diuretic bumetanide: a case report. Acta Paediatr (2013) 0.82
Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study. Autism (2013) 0.82
Alterations in sociability and functional brain connectivity caused by early-life seizures are prevented by bumetanide. Neurobiol Dis (2015) 0.82
Paradoxical Benzodiazepine Response: A Rationale for Bumetanide in Neurodevelopmental Disorders? Pediatrics (2015) 0.81
Comparison of adverse reactions to bumetanide and furosemide. J Clin Pharmacol (1982) 0.81
Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients. J Clin Pharmacol (1998) 0.81
Response to Comment on "Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring". Science (2014) 0.81
The pharmacokinetics of bumetanide in the newborn infant. Biol Neonate (1997) 0.81
Differences between cation-chloride co-transporter functions in the visual cortex of pigmented and albino rats. Eur J Neurosci (2005) 0.80
A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism. J Child Adolesc Psychopharmacol (2015) 0.80
Bumetanide--the way to its chemical structure. J Clin Pharmacol (1982) 0.80
Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis. Pediatrics (2016) 0.78
Bumetanide in heart failure in infancy. Arch Dis Child (1977) 0.76
Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects. J Pharm Sci (1984) 0.76